SOX2-OT and breast carcinoma: Over-expressed SOX2OT has also been confirmed in patients with small-cell lung cancer20, hepatocellular carcinoma21, breast cancer, etc. Functionally, consistanted with our results, SOX2OT performs oncogenic actions in bladder cancer22, pancreatic cancer23, gastric cancer24 cells.